<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    CohBar, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, Type 2 diabetes (T2D), cancer, cardiovascular disease and CNS disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven B. Engle, M.S.
    • FOUNDED
      2007
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    ProPhase Labs, Inc.

    ProPhase Labs, Inc.

    ProPhase Labs is a diversified medical science and technology company. We develop,...

    ProPhase Labs is a diversified medical science ...

    Filing Type:    PU
    Infinity Pharmaceuticals, Inc.

    Infinity Pharmaceuticals, Inc.

    Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company dedicate...

    Infinity Pharmaceuticals, Inc. is an innovative...

    Filing Type:    PU
    R1 RCM Inc.

    R1 RCM Inc.

    R1 is a leading provider of revenue cycle services and physician advisory services...

    R1 is a leading provider of revenue cycle servi...

    Filing Type:    PU
    BeyondSpring, Inc.

    BeyondSpring, Inc.

    Headquartered in New York, BeyondSpring Inc. (BeyondSpring) is a global, clinical-...

    Headquartered in New York, BeyondSpring Inc. (B...

    Filing Type:    PU
    Unum Therapeutics Inc.

    Unum Therapeutics Inc.

    Unum Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Unum Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    Millendo Therapeutics, Inc.

    Millendo Therapeutics, Inc.

    Millendo Therapeutics is a late-stage biopharmaceutical company primarily focused ...

    Millendo Therapeutics is a late-stage biopharma...

    Filing Type:    PU
    Aduro Biotech, Inc.

    Aduro Biotech, Inc.

    Aduro is dedicated to its mission to discover, develop, and commercialize immunoth...

    Aduro is dedicated to its mission to discover, ...

    Filing Type:    PU
    Tyme Technologies, Inc.

    Tyme Technologies, Inc.

    Tyme Inc. is an emerging biotechnology company developing cancer therapeutics that...

    Tyme Inc. is an emerging biotechnology company ...

    Filing Type:    PU
    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc. an early stage digital diagnostics company with the core m...

    20/20 GeneSystems, Inc. an early stage digital ...

    Fundraising Status:    SASBEC
    Filing Type:    RA
    DexCom, Inc.

    DexCom, Inc.

    Founded in 1999, Dexcom, Inc. is the leader in transforming diabetes care and mana...

    Founded in 1999, Dexcom, Inc. is the leader in ...

    Filing Type:    PU
    Insulet Corporation

    Insulet Corporation

    Insulet Corporation is an innovative medical device company based in Acton, Massac...

    Insulet Corporation is an innovative medical de...

    Filing Type:    PU
    Beta Bionics, Inc.

    Beta Bionics, Inc.

    Beta Bionics develops an integrated bionic pancreas system called the iLet.

    Beta Bionics develops an integrated bionic panc...

    Amount Raised:    $126,600,000
    Fundraising Status:    SB
    Filing Type:    CF
    Kitov Pharma Ltd.

    Kitov Pharma Ltd.

    Kitov Pharma is an innovative biopharmaceutical drug development company. Leveragi...

    Kitov Pharma is an innovative biopharmaceutical...

    Filing Type:    PU
    AtriCure, Inc.

    AtriCure, Inc.

    As a leading provider of innovative technologies for the treatment of Atrial Fibri...

    As a leading provider of innovative technologie...

    Filing Type:    PU
    PLx Pharma Inc.

    PLx Pharma Inc.

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage specialty pharmaceutical company i...

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.